MMP1 and prostate carcinoma: In the absence of overexpressed ETV1, ectopic JMJD2A slightly activated the MMP1 LUC reporter construct in human LNCaP prostate cancer cells, but there was no statistically significant difference between WT JMJD2A and the various methylation site mutants (Figure 3A).